SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-19-006616
Filing Date
2019-05-28
Accepted
2019-05-28 16:41:06
Documents
11
Period of Report
2019-05-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form6-k_proxy.htm 6-K 19210
2 EXHIBIT 99.1 exh_991.htm EX-99.1 33104
3 EXHIBIT 99.2 exh_992.htm EX-99.2 515055
4 EXHIBIT 99.3 exh_993.htm EX-99.3 7073
5 EXHIBIT 99.4 exh_994.htm EX-99.4 1794
6 EXHIBIT 99.5 exh_995.htm EX-99.5 11862
7 IMAGE astlogo.jpg GRAPHIC 3288
8 IMAGE ex992001.jpg GRAPHIC 35925
9 IMAGE exh_994000.jpg GRAPHIC 64446
10 IMAGE exh_994001.jpg GRAPHIC 135241
11 IMAGE intellipharmaceutics_logo.jpg GRAPHIC 7239
  Complete submission text file 0001654954-19-006616.txt   928805
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Filer) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 000-53805 | Film No.: 19858331
SIC: 2834 Pharmaceutical Preparations